{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:37Z","timestamp":1786986937109,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cll.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:46:40Z","timestamp":1757540800000},"page":"585-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-throughput Sequencing in the Diagnosis of Inherited Bleeding and Clotting Disorders"],"prefix":"10.1016","volume":"45","author":[{"given":"Anna P.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn D.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Trapp-Stamborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 6","key":"10.1016\/j.cll.2025.07.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.cll.2025.07.005_bib3","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025016512","article-title":"2025 ASH ISTH NBDF WFH Monitoring Report on Their 2021 Guidelines on Diagnosis and Management of von Willebrand Disease","author":"James","year":"2025","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jth.12792","article-title":"Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH","volume":"13","author":"Gresele","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2025.07.005_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ijlh.14266","article-title":"How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause","volume":"46","author":"Casini","year":"2024","journal-title":"Int J Lab Hematol"},{"issue":"7","key":"10.1016\/j.cll.2025.07.005_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-0032-1326783","article-title":"Approach to the diagnosis and management of common bleeding disorders","volume":"38","author":"Rydz","year":"2012","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"10.1016\/j.cll.2025.07.005_bib7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jth.13368","article-title":"A diagnostic approach to mild bleeding disorders","volume":"14","author":"Boender","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cll.2025.07.005_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2018.05.027","article-title":"Risk factors for inhibitor development in severe hemophilia a","volume":"168","author":"Garagiola","year":"2018","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-09-3879","article-title":"Bleeding in carriers of hemophilia","volume":"108","author":"Plug","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/hae.13366","article-title":"Type 2N von Willebrand disease: characterization and diagnostic difficulties","volume":"24","author":"Casonato","year":"2018","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.cll.2025.07.005_bib11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/hae.14174","article-title":"Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management","volume":"26","author":"Thomas","year":"2020","journal-title":"Haemophilia"},{"issue":"23","key":"10.1016\/j.cll.2025.07.005_bib12","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2015-12-688267","article-title":"A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders","volume":"127","author":"Simeoni","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.cll.2025.07.005_bib13","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.2018891192","article-title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","volume":"134","author":"Downes","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2025.07.005_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030763","article-title":"Strengths and weaknesses of light transmission aggregometry in diagnosing hereditary platelet function disorders","volume":"9","author":"Alessi","year":"2020","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.cll.2025.07.005_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.39571","article-title":"Rates and classification of variants of uncertain significance in hereditary disease genetic testing","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.cll.2025.07.005_bib16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type 1 deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.cll.2025.07.005_bib17","series-title":"GeneReviews\u00ae [internet]","first-page":"1993","article-title":"Complete plasminogen activator inhibitor 1 deficiency","author":"Heiman","year":"2017"},{"key":"10.1016\/j.cll.2025.07.005_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/JBM.S71319","article-title":"Glanzmann\u2019s thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options","volume":"6","author":"Solh","year":"2015","journal-title":"J Blood Med"},{"issue":"4","key":"10.1016\/j.cll.2025.07.005_bib19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2018.214239","article-title":"Glanzmann thrombasthenia: genetic basis and clinical correlates","volume":"105","author":"Botero","year":"2020","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.cll.2025.07.005_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/09537104.2019.1585528","article-title":"RASGRP2 gene variations associated with platelet dysfunction and bleeding","volume":"30","author":"Palma-Barqueros","year":"2019","journal-title":"Platelets"},{"issue":"19","key":"10.1016\/j.cll.2025.07.005_bib21","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1182\/blood-2009-01-198853","article-title":"LAD syndromes: FERMT3 kindles the signal","volume":"113","author":"Zimmerman","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-019-0709-6","article-title":"Platelet integrin \u03b1IIb\u03b23: signal transduction, regulation, and its therapeutic targeting","volume":"12","author":"Huang","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"6","key":"10.1016\/j.cll.2025.07.005_bib23","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood-2009-07-233965","article-title":"Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene","volume":"115","author":"Paterson","year":"2010","journal-title":"Blood"},{"issue":"7905","key":"10.1016\/j.cll.2025.07.005_bib24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","article-title":"A joint NCBI and EMBL-EBI transcript set for clinical genomics and research","volume":"604","author":"Morales","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cll.2025.07.005_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/gm543","article-title":"Choice of transcripts and software has a large effect on variant annotation","volume":"6","author":"McCarthy","year":"2014","journal-title":"Genome Med"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.10.013","article-title":"Importance of adopting standardized MANE transcripts in clinical reporting","volume":"25","author":"Wright","year":"2023","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.cll.2025.07.005_bib27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.cll.2025.07.005_bib28","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41436-021-01187-w","article-title":"One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation","volume":"23","author":"Lincoln","year":"2021","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.cll.2025.07.005_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A","volume":"5","author":"Lakich","year":"1993","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood.V99.1.168","article-title":"Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A","volume":"99","author":"Bagnall","year":"2002","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.cll.2025.07.005_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/bloodadvances.2016002923","article-title":"Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the my life, our future initiative","volume":"1","author":"Johnsen","year":"2017","journal-title":"Blood Adv"},{"issue":"6160","key":"10.1016\/j.cll.2025.07.005_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/332164a0","article-title":"Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man","volume":"332","author":"Kazazian","year":"1988","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/bib\/bbv028","article-title":"Robust and exact structural variation detection with paired-end and soft-clipped alignments: softsv compared with eight algorithms","volume":"17","author":"Bartenhagen","year":"2016","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.cll.2025.07.005_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119884","article-title":"Detection of hemophilia A genetic variants using third-generation long-read sequencing","volume":"562","author":"Ling","year":"2024","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.cll.2025.07.005_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.cll.2025.07.005_bib36","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/s41436-018-0432-7","article-title":"A survey assessing adoption of the ACMG-AMP guidelines for interpreting sequence variants and identification of areas for continued improvement","volume":"21","author":"Niehaus","year":"2019","journal-title":"Genet Med"},{"issue":"23","key":"10.1016\/j.cll.2025.07.005_bib37","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen--the clinical genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","article-title":"Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American college of medical genetics and genomics (ACMG) and the clinical genome resource (ClinGen)","volume":"22","author":"Riggs","year":"2020","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.cll.2025.07.005_bib39","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/gim.2017.210","article-title":"Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework","volume":"20","author":"Tavtigian","year":"2018","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajhg.2023.11.009","article-title":"ClinGen guidance for use of the PP1\/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification","volume":"111","author":"Biesecker","year":"2024","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib41","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1002\/cphg.93","article-title":"Overview of specifications to the ACMG\/AMP variant interpretation guidelines","volume":"103","author":"Harrison","year":"2019","journal-title":"Curr Protoc Hum Genet"},{"issue":"11","key":"10.1016\/j.cll.2025.07.005_bib42","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/jth.13843","article-title":"Thrombocytopenia and CD34 expression is decoupled from \u03b1-granule deficiency with mutation of the first growth factor-independent 1B zinc finger","volume":"15","author":"Rabbolini","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.cll.2025.07.005_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27874","article-title":"Macrothrombocytopenia associated with a rare GFI1B missense variant confounding the presentation of immune thrombocytopenia","volume":"66","author":"Cheng","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/ijlh.12763","article-title":"Mean platelet diameter measurements to classify inherited thrombocytopenias","volume":"40","author":"Fixter","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"11","key":"10.1016\/j.cll.2025.07.005_bib45","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/jth.12368","article-title":"GFI1B mutation causes a bleeding disorder with abnormal platelet function","volume":"11","author":"Stevenson","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.cll.2025.07.005_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa1308130","article-title":"A dominant-negative GFI1B mutation in the gray platelet syndrome","volume":"370","author":"Monteferrario","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.cll.2025.07.005_bib47","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/jth.13350","article-title":"Functional characterization of a novel GFI1B mutation causing congenital macrothrombocytopenia","volume":"14","author":"Kitamura","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.cll.2025.07.005_bib48","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ymgme.2016.12.006","article-title":"Combined alpha-delta platelet storage pool deficiency is associated with mutations in GFI1B","volume":"120","author":"Ferreira","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00001721-200501000-00013","article-title":"A case of deficiency of plasma plasminogen activator inhibitor-1 related to Ala15Thr mutation in its signal peptide","volume":"16","author":"Zhang","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"10.1016\/j.cll.2025.07.005_bib50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3892\/etm_00000090","article-title":"Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1","volume":"1","author":"Jankun","year":"2010","journal-title":"Exp Ther Med"},{"issue":"11","key":"10.1016\/j.cll.2025.07.005_bib51","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1538-7836.2009.03594.x","article-title":"Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function","volume":"7","author":"Flood","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2141.2002.03617.x","article-title":"A Tyr346Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy","volume":"118","author":"Mumford","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2516.2007.01557.x","article-title":"Tyr346Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype - is this mild haemophilia A?","volume":"14","author":"Lyall","year":"2008","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.cll.2025.07.005_bib58","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/09537104.2020.1786041","article-title":"A novel homozygous GFI1B variant in 2 sisters with thrombocytopenia and severe bleeding tendency","volume":"32","author":"Br\u00f8ns","year":"2021","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ajhg.2016.06.016","article-title":"Whole-exome sequencing identifies loci associated with blood cell traits and reveals a role for alternative GFI1B splice variants in human hematopoiesis","volume":"99","author":"Polfus","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"6204","key":"10.1016\/j.cll.2025.07.005_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/science.1251033","article-title":"Transcriptional diversity during lineage commitment of human blood progenitors","volume":"345","author":"Chen","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cll.2025.07.005_bib61","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/rth2.12151","article-title":"A comprehensive targeted next-generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia","volume":"2","author":"Johnson","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"10.1016\/j.cll.2025.07.005_bib62","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.3324\/haematol.2018.207712","article-title":"Inherited missense variants that affect GFI1B function do not necessarily cause bleeding diatheses","volume":"104","author":"van Oorschot","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib63","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2023.2237592","article-title":"An oligogenic case of severe neonatal thrombocytopenia and a purportedly benign variant in GFI1B requiring reinterpretation","volume":"34","author":"Frenkel","year":"2023","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(94)00138-4","article-title":"The protein C anticoagulant system: inherited defects as basis for venous thrombosis","volume":"77","author":"Dahlb\u00e4ck","year":"1995","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.cll.2025.07.005_bib65","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1038\/s41436-019-0560-8","article-title":"Considerations for clinical curation, classification, and reporting of low-penetrance and low effect size variants associated with disease risk","volume":"21","author":"Senol-Cosar","year":"2019","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101305","article-title":"Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: framework for genetics Clinicians and clinical scientists by CanVIG-UK (cancer variant interpretation Group-UK)","volume":"27","author":"Garrett","year":"2025","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.cll.2025.07.005_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.101036","article-title":"Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen low penetrance\/risk allele working group","volume":"26","author":"Schmidt","year":"2024","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.cll.2025.07.005_bib68","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41436-018-0347-3","article-title":"Increasing evidence of combinatory variant effects calls for revised classification of low-penetrance alleles","volume":"21","author":"Wang","year":"2019","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.cll.2025.07.005_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40246-022-00407-x","article-title":"Expanding ACMG variant classification guidelines into a general framework","volume":"16","author":"Masson","year":"2022","journal-title":"Hum Genomics"},{"issue":"2","key":"10.1016\/j.cll.2025.07.005_bib70","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41431-021-00903-z","article-title":"Stepwise ABC system for classification of any type of genetic variant","volume":"30","author":"Houge","year":"2022","journal-title":"Eur J Hum Genet"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:23:40Z","timestamp":1761618220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271225000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0272271225000599"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2025.07.005","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput Sequencing in the Diagnosis of Inherited Bleeding and Clotting Disorders","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}